Teva Pharmaceutical Industries Limited Stock Price and Value Analysis

Should you buy Teva Pharmaceutical Industries Limited stock? (NYSE:TEVA). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Teva Pharmaceutical Industries Limited to reach your target.

Target type

TEVA Free Cash Flow Trend

Free Cash Flow trendline for TEVA
Free Cash Flow trendline for Teva Pharmaceutical Industries Limited
CSV

Based on historical returns, we believe that Teva Pharmaceutical Industries Limited can grow its free cash at a rate of about 4%. That's positive!

AdvantagesDisadvantagesNeutral
  • This stock is on sale.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This company pays no dividend.

Inside the TEVA Numbers

TEVA Price
(Teva Pharmaceutical Industries Limited stock price per share)
$38.98
[?] TEVA Fair Price
(based on intrinsic value)
$50.62
[?] TEVA Safety Price (based on a variable margin of safety) $30.37
[?] PE Ratio versus Sector 220% higher than other Healthcare stocks
[?] PE Ratio versus Industry 1186% higher than other Drug Manufacturers - General stocks
[?] Cash Yield 13.37%
[?] Free Cash Flow Jitter 155%

Recent Insider Activity

Open-market buys and sells reported by Teva Pharmaceutical Industries Limited's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2026-08-21T00:00:00 Weiss Amir (Chief Accounting Officer) Sell 6,945 $37.61
2026-08-21T00:00:00 Weiss Amir (Chief Accounting Officer) Sell 2,500 $37.63
2026-08-21T00:00:00 Satchi-Fainaro Ronit Sell 415 $37.25
2026-08-17T00:00:00 Lippman Evan (EVP, Business Development) Sell 18,600 $36.57
2026-08-05T00:00:00 Zaks Tal Zvi Sell 17 $34.87
2026-08-03T00:00:00 Hughes Eric A (See "Remarks") Sell 25,578 $34.88
2026-08-03T00:00:00 Jover Placid (See "Remarks") Sell 12,827 $34.88
2026-06-18T00:00:00 Shields Matthew (EVP, Global Operations) Sell 9,989 $32.19
2026-06-11T00:00:00 Kalif Eliyahu Sharon (EVP, Chief Financial Officer) Sell 106,563 $34.10
2026-06-05T00:00:00 Francis Richard D (President and CEO) Sell 6,153 $34.35

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is Teva Pharmaceutical Industries Limited Stock on Sale?

We believe that Teva Pharmaceutical Industries Limited may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Teva Pharmaceutical Industries Limited looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.

Advertisement supports free stock analysis content.

Should You Buy TEVA Stock?

Does Teva Pharmaceutical Industries Limited have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: TEVA

This example shows how we apply the Trendshare checklist to TEVA: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 38.98
    • Market cap: $45B
    • EPS: 0.6
  2. Step 2 — Valuation checks

    • P/E: 64.967
    • FCF yield: 13.4%
    • Date checked: Sep 18, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.

Most Popular Articles